• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Provider perceptions of system-level opioid prescribing and addiction treatment policies.提供者对系统层面阿片类药物处方和成瘾治疗政策的看法。
Curr Opin Psychol. 2019 Dec;30:65-73. doi: 10.1016/j.copsyc.2019.01.018. Epub 2019 Feb 4.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review.州级和系统级阿片类药物处方政策:对医疗服务提供者行为及过量用药死亡的影响,一项系统综述
J Opioid Manag. 2016 May-Jun;12(2):109-18. doi: 10.5055/jom.2016.0322.
4
Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing.利用药物基因组学数据支持阿片类药物处方的障碍、解决方案和效果。
J Manag Care Spec Pharm. 2020 Dec;26(12):1597-1602. doi: 10.18553/jmcp.2020.26.12.1597.
5
FDA Boxed Warning for Immediate-Release Opioids.美国食品药品监督管理局(FDA)对速释阿片类药物的黑框警告。
J Pain Palliat Care Pharmacother. 2016 Jun;30(2):141-5. doi: 10.3109/15360288.2016.1173762.
6
The US Opioid Crisis: Current Federal and State Legal Issues.美国阿片类药物危机:当前联邦和州的法律问题。
Anesth Analg. 2017 Nov;125(5):1675-1681. doi: 10.1213/ANE.0000000000002403.
7
The opioid crisis: Origins, trends, policies, and the roles of pharmacists.阿片类药物危机:起源、趋势、政策以及药剂师的作用。
Am J Health Syst Pharm. 2019 Mar 19;76(7):424-435. doi: 10.1093/ajhp/zxy089.
8
The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.州级阿片类药物滥用预防政策与患者和医疗服务提供者相关结局的关联:范围综述。
Milbank Q. 2020 Mar;98(1):57-105. doi: 10.1111/1468-0009.12436. Epub 2019 Dec 4.
9
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
10
Prescriber Education Interventions to Optimize Opioid Prescribing in Acute Care: A Systematic Review.优化急性护理中阿片类药物处方的处方教育干预措施:系统评价。
Pain Physician. 2019 Nov;22(6):E551-E562.

引用本文的文献

1
Social and cognitive determinants of medications for opioid use disorder outcomes: A systematic review using a social determinants of health framework.阿片类物质使用障碍治疗药物疗效的社会和认知决定因素:一项基于健康社会决定因素框架的系统评价
Appl Neuropsychol Adult. 2024 Apr 25:1-25. doi: 10.1080/23279095.2024.2336195.
2
Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study.美国农村地区药物使用人群中阿片类使用障碍治疗障碍:一项定性、多地点研究。
Soc Sci Med. 2024 Apr;346:116660. doi: 10.1016/j.socscimed.2024.116660. Epub 2024 Feb 13.
3
Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis.医生在开阿片类药物时实施减轻风险策略的观点:定性分析。
BMC Health Serv Res. 2023 Oct 31;23(1):1185. doi: 10.1186/s12913-023-10136-z.
4
Variation in opioid filling after same-day breast surgery in Ontario, Canada: a population-based cohort study.加拿大安大略省同日乳房手术后阿片类药物填充的变化:一项基于人群的队列研究。
CMAJ Open. 2023 Mar 7;11(2):E208-E218. doi: 10.9778/cmajo.20220055. Print 2023 Mar-Apr.
5
A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.对导致过量用药危机的社会和行为因素的批判性回顾。
Annu Rev Public Health. 2021 Apr 1;42:95-114. doi: 10.1146/annurev-publhealth-090419-102727. Epub 2021 Nov 30.
6
Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS.修改和评估处方类阿片药物阿片类药物过量知识量表:Rx-OOKS 的初步研究。
Pain Med. 2020 Oct 1;21(10):2244-2252. doi: 10.1093/pm/pnaa190.
7
The Public Health Value of Opioid Litigation.阿片类药物诉讼的公共卫生价值。
J Law Med Ethics. 2020 Jun;48(2):279-292. doi: 10.1177/1073110520935340.
8
The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.州级阿片类药物滥用预防政策与患者和医疗服务提供者相关结局的关联:范围综述。
Milbank Q. 2020 Mar;98(1):57-105. doi: 10.1111/1468-0009.12436. Epub 2019 Dec 4.
9
Prescription Drug Monitoring Programs - Friend or Folly in Addressing the Opioid-Overdose Crisis?处方药监测计划——应对阿片类药物过量危机的助力还是 folly? (注:folly 直译为“愚蠢行为”,这里结合语境意译为“无用之举”之类表述会更合适,但按要求不添加其他说明,保留 folly)
N Engl J Med. 2019 Aug 22;381(8):699-701. doi: 10.1056/NEJMp1904714.

本文引用的文献

1
Drug Overdose Deaths in the United States, 1999-2017.1999 - 2017年美国药物过量致死情况
NCHS Data Brief. 2018 Nov(329):1-8.
2
Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.利用处方药物监测计划进行处方和配药决策:一项多地点定性研究的结果。
Res Social Adm Pharm. 2019 Jun;15(6):754-760. doi: 10.1016/j.sapharm.2018.09.007. Epub 2018 Sep 14.
3
Prescription Drug Monitoring Programs: Relationships Among Program Awareness, Use, and State Mandates.处方药监测计划:计划认知、使用与州规定之间的关系
J Pain Palliat Care Pharmacother. 2018 Jun-Sep;32(2-3):129-133. doi: 10.1080/15360288.2018.1488793. Epub 2018 Sep 10.
4
Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.在接受关于强制使用宾夕法尼亚州处方药监测计划的教育后,评估急诊科阿片类药物的处方行为。
J Addict Nurs. 2018 Jul/Sep;29(3):196-202. doi: 10.1097/JAN.0000000000000236.
5
Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.在基层医疗环境中开具纳洛酮处方的可接受性和可行性:系统评价。
Prev Med. 2018 Sep;114:79-87. doi: 10.1016/j.ypmed.2018.06.005. Epub 2018 Jun 15.
6
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages.四个拥有健全的处方药物监测项目的州减少了阿片类药物用量。
Health Aff (Millwood). 2018 Jun;37(6):964-974. doi: 10.1377/hlthaff.2017.1321.
7
Surgery program directors' knowledge of opioid prescribing regulations: a survey study.外科项目主任对阿片类药物处方规定的了解:一项调查研究。
J Surg Res. 2018 Jul;227:194-197. doi: 10.1016/j.jss.2018.02.036. Epub 2018 Mar 20.
8
Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing?对美国疾病控制与预防中心(CDC)指南的熟悉程度、继续教育以及医疗服务提供者的特征是否会影响对慢性疼痛管理实践和阿片类药物处方的依从性?
J Opioid Manag. 2018 Mar-Apr;14(2):103-116. doi: 10.5055/jom.2018.0437.
9
A Multistep Approach to Address Clinican Knowledge, Attitudes, and Behavior Around Opioid Prescribing.一种解决临床医生在阿片类药物处方方面的知识、态度和行为问题的多步骤方法。
WMJ. 2018 Mar;117(1):38-41.
10
Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.在退伍军人事务医疗中心实施和评估阿片类药物过量教育和纳洛酮分发 (OEND) 计划。
Subst Abus. 2018;39(2):206-210. doi: 10.1080/08897077.2018.1449174.

提供者对系统层面阿片类药物处方和成瘾治疗政策的看法。

Provider perceptions of system-level opioid prescribing and addiction treatment policies.

机构信息

Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, United States.

Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI, United States.

出版信息

Curr Opin Psychol. 2019 Dec;30:65-73. doi: 10.1016/j.copsyc.2019.01.018. Epub 2019 Feb 4.

DOI:10.1016/j.copsyc.2019.01.018
PMID:30856591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7482312/
Abstract

Stakeholders have implemented a multitude of system-level policies to address the U.S. opioid overdose epidemic. Because opioid prescribing partly fueled the crisis and because prescribing of medications for opioid addiction treatment is a key prevention strategy, it is critical to understand prescriber perceptions of policies in these domains. This article reviews prescriber awareness and opinions of the following system-level policies: opioid prescribing guidelines, prescription drug monitoring programs (PDMPs), medications for addiction treatment, and naloxone distribution programs. Most providers are aware of these policies, especially PDMPs, albeit a smaller proportion actively participate in their implementation. Low engagement in certain system-level policies is concerning and deserves attention, given that prescribers play an integral role in achieving optimal impact and mitigating the crisis.

摘要

利益相关者已经实施了许多系统层面的政策来解决美国阿片类药物过量流行的问题。由于阿片类药物的处方在一定程度上加剧了这场危机,而且处方治疗阿片类药物成瘾的药物是一种关键的预防策略,因此了解处方医生对这些领域政策的看法至关重要。本文回顾了处方医生对以下系统层面政策的认知和意见:阿片类药物处方指南、处方药物监测计划 (PDMP)、成瘾治疗药物和纳洛酮分发计划。大多数提供者都了解这些政策,尤其是 PDMP,尽管只有一小部分人积极参与其实施。某些系统层面政策的参与度低令人担忧,值得关注,因为医生在实现最佳效果和缓解危机方面发挥着不可或缺的作用。